The 14-3-3η Biomarker Platform for Diagnosis and Prognostic Monitoring of Patients with Rheumatoid Arthritis
Introduction. There are several gaps in the clinical evaluation and management of patients with rheumatoid arthritis (RA) that could be addressed through the development of new biomarkers. These include diagnostic biomarkers for primary care physicians that facilitate early referral to a rheumatolog...
Saved in:
| Main Author: | W. Maksymowych |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Publishing House "Kyrylytsya"
2024-03-01
|
| Series: | Львівський клінічний вісник |
| Subjects: | |
| Online Access: | https://lcb-journal.com/index.php/journal/article/view/81 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
14–3-3 eta (η) protein as a promising marker for rheumatoid arthritis: relation to joint damage and subclinical atherosclerosis
by: Sahar A. Elsayed, et al.
Published: (2025-03-01) -
Study of 14-3-3 η eta protein in juvenile idiopathic arthritis
by: Khaled Omar Elfarouk Zaiton, et al.
Published: (2025-06-01) -
Study of rheumatoid arthritis in older patients: a cross-sectional study
by: Ramesh Kumar Sah, et al.
Published: (2025-07-01) -
New laboratory biomarkers of rheumatoid arthritis
by: D. A. Dibrov
Published: (2021-05-01) -
Relationship of Serum 3-Nitrotyrosine Levels with Inflammation in Patients with Rheumatoid Arthritis
by: Juan C. Quevedo-Abeledo, et al.
Published: (2025-05-01)